rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Side effects of drugs annual
    sub title: a worldwide yearly survey of new data in adverse drug reactions
    part number: Volume 37
  name:
    name part: Ray, Sidhartha D.
    role:
      role term: editor.
  name:
    name part: ScienceDirect (Online service)
  type of resource: text
  genre: Electronic books.
  origin info:
    place:
      place term: ne
    date issued: 2015
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: 1 online resource
  abstract: Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 40, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing each year. Topics covered in this release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressant drugs, Lithium, Drugs of abuse, Hypnotics and sedatives, Antipsychotic Drugs, and much more.
  table of contents: Title page; Table of Contents; Copyright; Contributors; Preface; Special Reviews in SEDA 37; Table of Essays, Annuals 1-36; Abbreviations; ADRs, ADEs and SEDs: A Bird's Eye View; I Introduction; References on Adverse Drug Reactions; II Pharmacogenomics Considerations; References Pharmacogenomics Considerations; III Immunological Reactions; References; IV Analysis of Toxicological Reactions; References; V Grades of Adverse Drug Reactions; References; VI FDA Pregnancy Categories/Classification of teratogenicity; References; Conclusion.
  table of contents: Chapter 1: Central Nervous System Stimulants and Drugs That Suppress AppetiteAbstract; Methylxanthines; Vigilance Promoting Drugs; Parasympathomimetics [SEDA-32, 19; SEDA-33, 15; SEDA-34, 9]; Chapter 2: Antidepressants; Abstract; General; Selective Serotonin Re-Uptake Inhibitors (SSRIs) [SED-15, 3109; SEDA-31, 18; SEDA-32, 33; SEDA-33, 26; SEDA-34, 17; SEDA-35, 30; SEDA-36, 14]; Serotonin and Noradrenaline Re-Uptake Inhibitors (SNRIs); Other Antidepressants; Chapter 3: Lithium; Abstract; Introduction; Organs and Systems; Second-Generation Effects; Susceptibility Factors; Interactions.
  table of contents: Diagnosis of Adverse Drug ReactionsManagement of Adverse Drug Reactions; Pharmacogenomics; Chapter 4: Drugs of Abuse; Abstract; Introduction; Cannabinoid; Alcohol; Benzodiazepines; Sympathomimetics-Cocaine; Opioids-Heroin; Electronic Cigarettes (E-Cigarettes); Conclusion; Chapter 5: Hypnosedatives and Anxiolytics; Abstract; Benzodiazepines; Hypnosedatives and Benzodiazepine-Like Drugs; Chapter 6: Antipsychotic Drugs; Abstract; General [SEDA-15, 2438; SEDA-32, 83; SEDA-33, 89; SEDA-34, 51; SEDA-35, 85; SEDA-36, 59]; Individual Drugs; Acknowledgements; Chapter 7: Antiepileptics; Abstract.
  table of contents: Chapter 8: Opioid Analgesics and Narcotic AntagonistsAbstract; Opioid Receptor Agonists; Alfentanil [SED-15, 72; SEDA-34, 152; SEDA-35, 173; SEDA-36, 108]; Codeine [SED-15, 880; SEDA -34, 152; SEDA-35, 174; SEDA-36, 108]; Dextrometrophan [SED-15, 1088; SEDA-34, 153; SEDA-35, 174; SEDA-36, 108]; Diamorphine [SED-15, 1096; SEDA-34, 153; SEDA-35, 175; SEDA-36, 108]; Dihydrocodeine [SED-15, 1125; SEDA-34, 154; SEDA-35, 175; SEDA-36, 108]; Fentanyl [SED-15, 1346; SEDA-34, 154; SEDA-35, 176; SEDA-36, 109]; Hydrocodone [SED-15, 1702; SEDA-34, 156; SEDA-35, 177; SEDA-36, 109]
  table of contents: Methadone [SED-15, 2270 SEDA-34, 157; SEDA-35, 177; SEDA-36, 110]; Morphine [SED-15, 2386; SEDA-34, 159; SEDA-35, 181; SEDA-36, 111]; Oxycodone [SED-15, 2651; SEDA-34, 161; SEDA-35, 182; SEDA-36, 111]; Papaverine [SED-15, 2678; SEDA-34, 162; SEDA-35, 183; SEDA-36, 112]; Pethidine (Meperidine) [SED-15, 2791; SEDA-34, 163; SEDA-35, 183; SEDA-36, 112]; Remifentanyl [SED-15, 3030; SEDA-34, 163; SEDA-35, 184; SEDA-36, 112]; Tramadol [SED-15, 3469; SEDA-34, 165; SEDA-35, 184; SEDA-36, 112]; Partial Opioid Receptor Agonists; Opioid Receptor Antagonists; Naloxone [SED-15, 2421.
  note: edited by Sidhartha D. Ray.
  note: Includes indexes.
  subject:
    topic: Drugs
    topic: Side effects
  subject:
    topic: Drug-Related Side Effects and Adverse Reactions
  subject:
    topic: Médicaments
    topic: Effets secondaires
  subject:
    topic: MEDICAL
    topic: Pharmacology
  subject:
    topic: Drugs
    topic: Side effects
  classification: RM302.5
  classification: 615.7/042
  related item:
    identifier: (OCoLC)919479584
  identifier: 9780444635310
  identifier: 0444635319
  identifier: 9780444635259
  identifier: 0444635254
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: OPELS
    record creation date: 151118
    record change date: 20260327145829.9
    record identifier: in00005759839
    language of cataloging:
      language term: eng